Standardisation of Quality of Life Trials Bert Spilker Guest Editorial 13 November 2012 Pages: 73 - 75
Health-Related Quality of Life in Pharmaceutical Evaluation Donald L. Patrick Guest Editorial 13 November 2012 Pages: 76 - 78
Health Services Needs and Related Costs for HIV Care Dennis P. AndrulisVirginia Beers Weslowski Leading Article 13 November 2012 Pages: 79 - 83
Quality of Life Instruments in the Evaluation of New Drugs Roman JaeschkeGordon H. GuyattDeborah Cook Review Article 13 November 2012 Pages: 84 - 93
Key Quality of Life Terms Used in the Evaluation of New Drugs R. JaeschkeG. H. GuyattD. Cook Guide Chart 13 November 2012 Pages: 94 - 94
Quality of Life Evaluation of Antihypertensive Drugs Christopher J. BulpittAstrid E. Fletcher Review Article 13 November 2012 Pages: 95 - 102
Pharmacoeconomics of Intravenous Drug Administration S. E. ParkerP. G. Davey Review Article 13 November 2012 Pages: 103 - 115
A Comparison of the Safety, Timing and Cost-Effectiveness of Administering Antibiotics by Intravenous Bolus (Push) Versus Intravenous Piggyback (Slow Infusion) in Surgical Prophylaxis James C. GarreltsDale F. SmithJerry D. Peterie Original Research Article 13 November 2012 Pages: 116 - 123
Simvastatin Paul ChrispNancy J. W. LewisRichard J. Milne Pharmacoeconomic Drug Evaluation 13 November 2012 Pages: 124 - 145
Efficacy and Cost-Effectiveness of Oral Ciprofloxacin Steven L. Barriere Current Comment 13 November 2012 Pages: 146 - 147
Monitoring Tricyclic Antidepressant Therapy Matthew V. Rudorfer Current Comment 13 November 2012 Pages: 148 - 150